Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
The International Journal of Artificial Organs
|
July 31, 1998
The mevalonate pathway and renal diseases: experimental and clinical implications
A Scoppola, P Galiano
Atherosclerosis
|
June 8, 2001
Urinary mevalonate excretion rate in type 2 diabetes: role of metabolic control
A Scoppola, F R Montecchi, G Menzinger, et al.
Metabolism: Clinical and Experimental
|
January 24, 1998
Apolipoprotein E genotype and cholesterogenesis in polygenic hypercholesterolemia
A Lala, A Scoppola, C Motti, et al.
Kidney International
|
March 1, 1997
Plasma mevalonate concentrations in uremic patients
A Scoppola, P De Paolis, G Menzinger, et al.
Annals of Nutrition & Metabolism
|
January 1, 1994
The effects of insulin on plasma mevalonate concentrations in man
A Lala, A Scoppola, A Ricci, et al.
Journal of Lipid Research
|
June 1, 1991
Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry
A Scoppola, V M Maher, G R Thompson, et al.
Acta Pathologica Japonica
|
November 1, 1989
An unusual hormone pattern in a virilized woman affected by Sertoli-Leydig cell tumor. Report of a case
M A Satta, G De Rosa, A Scoppola, et al.
Diabetes Care
|
October 1, 1995
Effects of insulin on cholesterol synthesis in type II diabetes patients
A Scoppola, G Testa, S Frontoni, et al.
Minerva Medica
|
December 1, 1989
[The relationship between high-density lipoproteins, thromboxane B2 and arteriosclerosis in a case of primary hypoalphalipoproteinemia]
M A Satta, A Scoppola, D Melina, et al.
The Quarterly Journal of Medicine
|
September 1, 1992
Possible mechanism and treatment of o,p'DDD-induced hypercholesterolaemia
V M Maher, P J Trainer, A Scoppola, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
The International Journal of Artificial Organs
|
July 31, 1998
The mevalonate pathway and renal diseases: experimental and clinical implications
A Scoppola, P Galiano
Atherosclerosis
|
June 8, 2001
Urinary mevalonate excretion rate in type 2 diabetes: role of metabolic control
A Scoppola, F R Montecchi, G Menzinger, et al.
Metabolism: Clinical and Experimental
|
January 24, 1998
Apolipoprotein E genotype and cholesterogenesis in polygenic hypercholesterolemia
A Lala, A Scoppola, C Motti, et al.
Kidney International
|
March 1, 1997
Plasma mevalonate concentrations in uremic patients
A Scoppola, P De Paolis, G Menzinger, et al.
Annals of Nutrition & Metabolism
|
January 1, 1994
The effects of insulin on plasma mevalonate concentrations in man
A Lala, A Scoppola, A Ricci, et al.
Journal of Lipid Research
|
June 1, 1991
Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry
A Scoppola, V M Maher, G R Thompson, et al.
Acta Pathologica Japonica
|
November 1, 1989
An unusual hormone pattern in a virilized woman affected by Sertoli-Leydig cell tumor. Report of a case
M A Satta, G De Rosa, A Scoppola, et al.
Diabetes Care
|
October 1, 1995
Effects of insulin on cholesterol synthesis in type II diabetes patients
A Scoppola, G Testa, S Frontoni, et al.
Minerva Medica
|
December 1, 1989
[The relationship between high-density lipoproteins, thromboxane B2 and arteriosclerosis in a case of primary hypoalphalipoproteinemia]
M A Satta, A Scoppola, D Melina, et al.
The Quarterly Journal of Medicine
|
September 1, 1992
Possible mechanism and treatment of o,p'DDD-induced hypercholesterolaemia
V M Maher, P J Trainer, A Scoppola, et al.
Page
of 2